| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 552830-51-0 | Resolvin E1 |
≥98% | | 询价 |
| 2 | 423744-89-2 | BC12 |
≥98% | | 询价 |
| 3 | 1962928-26-2 | BGC20-1531 HCl |
≥98% | | 询价 |
| 4 | 5939-37-7 | 7-Hydroxymethotrexate |
≥98% | | 询价 |
| 5 | 1170613-55-4 | A-967079 |
≥98% | | 询价 |
| 6 | | Eltrombopag sodium |
≥98% | | 询价 |
| 7 | 1615197-10-8 | BAY 61-3606 HCl |
≥98% | | 询价 |
| 8 | 141949-00-0 | EE 581 |
≥98% | | 询价 |
| 9 | 212391-63-4 | PD-166285 diHCl |
≥98% | | 询价 |
| 10 | 11076-29-2 | Streptomyces pepsin inhibitor |
≥98% | | 询价 |
| 11 | 1783256-96-1 | ACT-678689 |
≥98% | | 询价 |
| 12 | 78587-05-0 | Hexythiazox |
≥98% | | 询价 |
| 13 | 63524-05-0 | Strontium Malonate |
≥98% | | 询价 |
| 14 | 123040-69-7 | Arazasetron HCl(SENS-401) |
≥98% | | 询价 |
| 15 | 6484-74-8 | Pteroylhexaglutamylglutamic acid |
≥98% | | 询价 |
| 16 | 3601-19-2 | Ropizine |
≥98% | | 询价 |
| 17 | 27471-58-5 | Acetamide,N-(m-anisyl)-2-(p-butoxyphenoxy)-N-(2-(diethylamino)ethyl)-,hydrochloride |
≥98% | | 询价 |
| 18 | 1399103-28-6 | RO5487624 |
≥98% | | 询价 |
| 19 | 5424-19-1 | 3-Benzoylpyridine |
≥98% | | 询价 |
| 20 | 195068-07-6 | Sarizotan HCl |
≥98% | | 询价 |
| 21 | 639-43-0 | Akuammicine |
≥98% | | 询价 |
| 22 | 1951424-92-2 | Fmoc-Ala-Ala-Asn(Trt)-OH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 23 | | DSPE-PEG-CH2COOH(MW 5000) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 24 | | N-Fmoc-N'-(azido-PEG4)-L-Lysine-PFP ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 25 | | Propargyl-PEG4-hydrazide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 26 | 2353409-55-7 | Dde Biotin-PEG4-TAMRA-PEG4 Alkyne |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 27 | | TCO-PEG3-maleimide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 28 | 2107273-72-1 | N-(m-PEG4)-N'-(4-Hydroxycyclohexyl-1-amido-PEG4)-Cy5 |
≥98% | | 询价 |
| 29 | 653600-56-7 | Ac4GalNAz |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | | DSPE-PEG36-mal |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 2148986-06-3 | HS-PEG7-CH2CH2N3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 2107273-78-7 | N-(m-PEG4)-N'-(Biotin-PEG2-amido-PEG4)-Cy5 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 2378049-28-4 | Hydroxy-PEG7-CH2-Boc |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 880081-81-2 | m-PEG8-O-alkyne |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | | HO-PEG24-CH2COOH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | | Amino-PEG24-CH2-Boc |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 2378590-46-4 | Fmoc-NH-PEG15-CH2CH2COOH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | | DBCO-SS-aldehyde |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 1347750-20-2 | HS-PEG5-CH2CH2NH2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 40 | | Bis-Mal-PEG5 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 41 | 1640294-30-9 | ASP4132 tosylate |
≥98% | | 询价 |
| 42 | 919091-63-7 | RA-9 UPS inhibitor |
≥98% | | 询价 |
| 43 | 218136-59-5 | SC-26196 |
≥98% | | 询价 |
| 44 | 912780-51-9 | C-215 |
≥98% | | 询价 |
| 45 | | Tetrazine-Ph-PEG5-Ph-tetrazine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 46 | | Fmoc-NH-PEG16-CH2CH2COOH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 47 | 86099-06-1 | BM-PEG3 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | | Tri(Amino-PEG3-amide)-amine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 49 | | N-(m-PEG4)-N'-(PEG3-Mal)-Cy5 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 50 | | DBCO-mPEG(MW 5kDa) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 52190-55-3 | m-PEG4-SH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | 2107273-38-9 | N-(m-PEG4)-N'-(azide-PEG4)-Cy3 |
≥98% | | 询价 |
| 53 | | HS-C6-PEG9-acid |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 54 | | Mal-NH-PEG10-CH2CH2COOPFP ester |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 55 | 2375193-74-9 | DBCO-NH-(CH2)4COOH |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 56 | 64-02-8 | Edetate Sodium |
≥98% | | 询价 |
| 57 | 38412-46-3 | Aloenin |
≥98% | | 询价 |
| 58 | 21102-94-3 | BMY-7378 HCl(BMY73) |
≥98% | | 询价 |
| 59 | 1807537-31-0 | Benzyl-PEG6-CH2CO2tBu |
≥98% | | 询价 |
| 60 | 1681056-61-0 | OSMI-1 |
≥98% | | 询价 |
m.cnreagent.com